Zydus receives final approval from USFDA for Bosentan tablets for oral suspension 32 mg.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
18-Feb-2026
Download PDF
Zydus Lifesciences
Zydus receives final approval from USFDA for Bosentan tablets for oral suspension 32 mg.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]